1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
DarioHealth Corp.

DarioHealth Corp.

DRIO
DarioHealth Corp.US flagNASDAQ Capital Market
6.77
USD
-0.04
- -
49.50MMarket Cap

Total Valuation

DarioHealth Corp. carries a market capitalization of 49.50M, placing it among publicly traded companies globally. Its enterprise value stands at 44.42M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap49.50M
Enterprise Value44.42M

Share Statistics

DarioHealth Corp. currently has 7.30M shares outstanding.

Shares Outstanding7.30M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.54, and the price-to-book ratio stands at -0.07.

PE RatioN/A
PS Ratio1.54
PB Ratio-0.07
P/TBV Ratio-3.10
P/FCF Ratio-1.30
P/OCF Ratio-1.29

Enterprise Valuation

EV / Sales2.10
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

DarioHealth Corp. maintains a current ratio of 3.07, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 51.00, indicating elevated leverage, while an interest coverage ratio of -9.45 demonstrates limited ability to service its debt obligations.

Current Ratio3.07
Quick Ratio2.60
Debt / Equity51.00
Debt / EBITDA-0.99
Interest Coverage-9.45

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-37.22
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.09

Taxes

Income Tax140,000.00
Effective Tax RateN/A

Stock Price Statistics

DarioHealth Corp.'s stock has declined approximately -51.98582% over the past 52 weeks. The 50-day moving average sits at 7.34, while the 200-day moving average is 10.22.

Beta (5Y)N/A
52-Week Price Change-51.98582%
50-Day Moving Average7.34
200-Day Moving Average10.22
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, DarioHealth Corp. generated 21.19M in revenue and converted that into -40.74M in net income, yielding earnings per share of -10.02. EBITDA reached -32.15M, while operating income came in at -34.55M.

Revenue21.19M
Gross Profit11.98M
Operating Income-34.55M
Pretax Income-40.60M
Net Income-40.74M
EBITDA-32.15M
EBIT-34.55M
Earnings Per Share (EPS)-10.02

Balance Sheet

DarioHealth Corp. holds 20.01M in cash and equivalents against 31.82M in total debt, resulting in a net debt position of 15.95M. Total book value stands at -460.32M, with working capital of 19.38M providing operational flexibility.

Cash & Cash Equivalents20.01M
Total Debt31.82M
Net Debt15.95M
Equity (Book Value)-460.32M
Book Value Per Share-113.18
Working Capital19.38M

Cash Flow

DarioHealth Corp. produced -25.29M in operating cash flow over the past twelve months. After subtracting -142,000.00 in capital expenditures, free cash flow totaled -25.43M - equivalent to -6.25 per share.

Operating Cash Flow-25.29M
Capital Expenditures-142,000.00
Free Cash Flow-25.43M
FCF Per Share-6.25

Margins

DarioHealth Corp. operates with a gross margin of 56.55, reflecting its pricing power and cost economics. The operating margin of -163.06 and net profit margin of -192.23 provide insight into operational efficiency.

Gross Margin56.55
Operating Margin-163.06
Pretax Margin-191.57
Profit Margin-192.23
EBITDA Margin-151.71

Dividends & Yields

The company's payout ratio of 27.15 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio27.15
Shareholder Yield-53.64
FCF Yield-77.10

Stock Splits

DarioHealth Corp.'s most recent stock split took place on August 28, 2025 with a 20:1 split ratio.

Last Split Date8/28/2025
Split Ratio20:1

Scores

DarioHealth Corp. posts an Altman Z-Score of -23.02, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-23.02